Existing therapeutics, new applications in COVID-19. That’s the theme we’ll be discussing on Thursday, as we look at the desire to continue success of treating COVID-19 by repurposing drugs which are already on the market. As you might expect, there is a lot to discuss, and our agenda includes:

1. End-to-End Evidence Framework
2. Case Study: Anticoagulant Use in the VA
3. Panel Discussion of Ongoing Work with:
   1. Dr. Martin Landray (RECOVERY),
   2. Dr. Chris Seymour (REMAP-CAP for COVID-19),
   3. Dr. Neil Aggarwal (ACTIV at NIH) and
   4. Dr. Susanna Naggie (DCRI)